ALAB · Astera Labs

The thesis

Astera Labs shares are modestly more likely than not to beat the S&P 500 over the next three months because revenue is growing faster than the price reflects. Third-quarter revenue of $584.9 million beat the company's $540–560 million guide, and the $730–750 million fourth-quarter outlook sits well above the $655.8 million consensus. The fourth-quarter report, expected around 10 February 2027, settles whether Scorpio switch revenue keeps growing now that the first large customer ramps are largely complete.

Management's first appearance after the report, at the BMO Technology and Innovation Leaders Conference on 12 November 2026, supported the case on customer breadth. Investing.com's summary has management expecting four to five Scorpio X customers by the end of 2026 and a pipeline in the teens converting to shipments in 2027. The shares closed at $227.79 that day, against $230.91 on 11 November 2026.

The price reflects a sharp slowdown after the first Scorpio X ramps: TIKR put the forward price-to-earnings ratio at about 32 times on 5 November 2026, against a one-year average of 72 times and a peak of 143 times on 30 June 2026. The rating is Medium because the guided revenue step is large and dated, while customer concentration and the end of the initial ramps keep the next report open.

Bullish and bearish views on Astera Labs, Inc.

The bull case on Astera Labs, Inc. (ALAB), in brief: revenue beat the company's own guide. The bear case: the first Scorpio X ramps are largely done.

Bull case

• Revenue beat the company's own guide. Astera reported third-quarter revenue of $584.9 million on 3 November 2026, up 154% from a year earlier and 49% from the previous quarter, in its 8-K results exhibit. Adjusted earnings per share (EPS) were $1.32 against a $1.19 estimate, per Benzinga.
• The fourth-quarter outlook clears consensus. Management guided revenue of $730–750 million and adjusted EPS of $1.62–1.66 on 3 November 2026, against consensus of $655.8 million and $1.42 (Benzinga). Non-GAAP gross margin is guided to about 72%.
• More switch customers are lined up. At the 12 November 2026 BMO conference, management said a second international hyperscaler (a very large cloud operator) began shipping Scorpio X in the third quarter and that four to five customers are expected by year-end, per Investing.com. The same summary cites Leo memory-controller design wins at two hyperscalers.
• Content per AI accelerator keeps rising. Management told the 12 November 2026 conference that its silicon content per accelerator has risen from about $50 four years ago to more than $1,000 today, per Investing.com.
• The valuation has reset. TIKR cited consensus normalized EPS of $4.03 for 2026 and $6.50 for 2027 on 5 November 2026, with the forward multiple near 32 times at that day's price.
• Analyst targets sit above the price. MarketBeat listed a $320.85 average target across 23 analysts (13 Buy, 10 Hold, no Sell) on 11 November 2026. Post-report targets include RBC's $400, Morgan Stanley's $389 (raised from $382) and BMO's $375 initiation.

Bear case

• The first Scorpio X ramps are largely done. On the 3 November 2026 call the chief financial officer said the initial Scorpio X platforms had completed much of their initial deployment ramps, per TIKR. New customers take pre-production volumes in the fourth quarter, so 2027 growth depends on conversions that have not yet shipped at volume.
• Revenue is concentrated in a few buyers. The top three end customers made up about 86% of 2025 revenue, according to the annual report cited by TIKR. The Yahoo Finance call summary lists reliance on a lead hyperscaler for Scorpio X growth as a risk.
• Gross margin is drifting lower. Non-GAAP gross margin was 73.7% in the second quarter and 72.4% in the third, with about 72% guided for the fourth, per the company's results. Revenue mix is moving from retimers toward lower-margin switches and modules.
• Most post-report target changes were cuts. After the 3 November 2026 report, RBC cut to $400 from $500, TD Cowen to $225 from $300 and Susquehanna to $258 from $310, per MarketBeat. Northland cut its 2027 EPS forecast to $4.79 from $5.43 while upgrading the shares.
• Insiders have sold steadily. SEC Form 4 filings show President and COO Sanjay Gajendra selling 90,630 shares at an average $340.35 on 17 August 2026 and director Manuel Alba selling 183,000 shares at an average $280.13 on 1 September 2026. Director Stefan Dyckerhoff sold 12,499 shares each month under a Rule 10b5-1 plan, most recently at $211.41 on 5 November 2026.

Price setup

The shares closed at $227.79 on 12 November 2026. The rebound from the post-report low close of $179.47 on 5 November 2026 ran through $190.71 on 6 November 2026, $216.87 on 9 November 2026, $216.18 on 10 November 2026 and $230.91 on 11 November 2026. The close on 12 November 2026, the day of the BMO conference, slipped from that level.

From adjusted daily closes as of 12 November 2026, the price sits under the 200-day moving average of $257.16 and the 50-day moving average of $295.49. A close back over the 200-day average would put the shares above their long trend line for the first time since the October sell-off. The 5 November 2026 close of $179.47 is the nearest reference low.

The shares are down 29.2% over three months from the $321.61 close of 14 August 2026. The last close is 54.4% below the $499.48 intraday 52-week high of 30 June 2026, and the 52-week closing low is $100.27 from 30 March 2026.

Catalysts ahead

• ~4 December 2026 (est.): S&P 500 quarterly rebalancing announcement. Being added would bring index-fund buying; being passed over would remove the index argument that lifted the shares on 6 October 2026.
• 8 December 2026: Astera Labs presents at the Raymond James TMT and Consumer Conference in New York. Management commentary on whether new Scorpio X customers move from pre-production to volume shipments, the main open question after the initial ramps.
• 9 December 2026: Astera Labs presents at the Barclays technology conference in San Francisco. A further read on first-quarter 2027 demand and gross margin as switches and modules grow in the mix.
• ~10 February 2027 (est.): Fourth-quarter 2026 results. Tests the $730–750 million revenue guide and the roughly 72% gross margin, and gives first-quarter 2027 guidance after the initial Scorpio X ramps; this report decides the case.

What would change the view

A daily close below $160, which would take the shares well under the 5 November 2026 post-report close of $179.47. Fourth-quarter revenue under the $730 million low end of guidance would also break the case.

The risks this note tracks, each with what would confirm it:

• Scorpio X growth pauses after the initial deployment ramps, which the chief financial officer said were largely complete on the 3 November 2026 call. Confirmed by: first-quarter 2027 guidance implying a decline in revenue from the previous quarter, or new customers staying at pre-production volumes into 2027.
• A lead hyperscaler's order pattern resets revenue, given that the top three end customers made up about 86% of 2025 revenue. Confirmed by: fourth-quarter revenue below the $730 million low end of guidance, or a lead cloud customer lowering capital-spending plans.
• The shift toward switches and modules erodes gross margin faster than the guided 72%. Confirmed by: reported fourth-quarter non-GAAP gross margin clearly under 72% (the third quarter was 72.4%, against 73.7% in the second).
• The AI chip sell-off resumes and compresses multiples regardless of company results. Confirmed by: another sector-wide rout like 5 November 2026, when Benzinga reported chip stocks' worst session since 2020, or hyperscalers cutting 2027 capital-spending plans.
• Insider selling adds supply into the rebound. Confirmed by: New SEC Form 4 filings showing officer or director sales well beyond the recurring 12,499-share monthly Rule 10b5-1 sales in November or December 2026.
• Analysts keep cutting estimates despite the guide. Confirmed by: more post-report cuts to 2027 earnings-per-share forecasts like Northland's move to $4.79 from $5.43, or targets falling below the share price.

What it trades with

The shares trade as a high-beta part of the AI semiconductor group. Benzinga reported on 15 October 2026 that the iShares Semiconductor ETF had logged a rare seven-day losing streak, and on 5 November 2026 it reported chip stocks' worst session since 2020, the day Astera closed at $179.47. MarketBeat tied the 6.8% gain on 11 November 2026 to a broad technology rally. The shares respond to the same hyperscaler capital-spending signals as Marvell, whose 6 October 2026 investor day lifted the group. Nasdaq-100 membership since 22 June 2026 ties daily flows to that index.